Table 66Summary of included studies. Comparison 65. Augmenting with exercise versus attention-placebo

StudyPopulationInterventionComparisonDetails of inadequate response/treatment resistanceComments

Lavretsky 2011

RCT

US

N=73

Mean age (years): 70.6

Gender (% female): 62

Ethnicity (% BME): NR

Baseline severity: HAMD 9 (less severe)

Tai Chi + escitalopram 10-20mg/day

Intensity: 10x 2-hour sessions

Attention-placebo (health education) + escitalopram 10-20mg/day

Intensity: 10x 2-hour sessions

Inadequate response to 4 weeks prospective treatment with escitalopram

Treatment length (weeks): 10

Outcomes:

  • Depression symptomatology endpoint
  • Remission
  • Discontinuation due to any reason
  • Sleeping difficulties emdpoint

Mather 2002

RCT

UK

N=86

Mean age (years): 65.0

Gender (% female): 69

Ethnicity (% BME): NR

Baseline severity: HAMD 17.05 (more severe)

Weight training class + any antidepressant

Intensity: 20x twice-weekly 45-min sessions

Attention-placebo (health education talks) + any antidepressant

Intensity: 20x twice-weekly 30-40 min sessions

Inadequate response: all participants had been in receipt of a therapeutic dose of antidepressant therapy for at least 6 weeks without evidence of a sustained response prior to study entry

Treatment length (weeks): 10

Outcomes:

  • Response
  • Discontinuation due to any reason

Mota-Pereira 2011

RCT

Portugal

N=33

Mean age (years): 47.5

Gender (% female): 66

Ethnicity (% BME): NR

Baseline severity: HAMD 17 (more severe)

Aerobic exercise + any antidepressant

Intensity: 60 sessions/12x 30-45min sessions supervised

Attention-placebo (social interaction with study staff and peers) + any antidepressant

Intensity: 12x 30-45min sessions

Inadequate response (failure to show clinical remission, HAMD>7) to combined therapy in doses considered adequate for 9-15 months

Treatment length (weeks): 12

Outcomes:

  • Depression symptomatology change score
  • Remission
  • Response
  • Discontinuation due to any reason
  • Global functioning change score

BME: black and minority ethnic; HAMD: Hamilton depression scale; NR: not reported; RCT: randomised controlled trial

From: Further-line treatment

Cover of Further-line treatment
Further-line treatment: Depression in adults: Evidence review D.
NICE Guideline, No. 222.
Copyright © NICE 2022.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.